{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:09:37Z","timestamp":1784761777228,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jfo.2014.04.010","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T16:52:58Z","timestamp":1410195178000},"page":"599-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacit\u00e9 et tol\u00e9rance des injections sous-conjonctivales de triamcinolone dans la prise en charge des \u0153d\u00e8mes maculaires uv\u00e9itiques\u00a0: \u00e9tude r\u00e9trospective sur trente et un cas"],"prefix":"10.1016","volume":"37","author":[{"given":"A.","family":"Bleriot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Couret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Le Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lebranchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2014.04.010_bib0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajo.2004.05.028","article-title":"Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection","volume":"138","author":"Inoue","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09273940500545684","article-title":"The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema","volume":"14","author":"Van Kooij","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2014.04.010_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina Phila Pa"},{"key":"10.1016\/j.jfo.2014.04.010_bib0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ajo.2007.04.011","article-title":"The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials","volume":"144","author":"Bhavsar","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0040","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0045","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0161-6420(00)00344-4","article-title":"Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose","volume":"107","author":"Weijtens","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2014.04.010_bib0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(99)00129-4","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2014.04.010_bib0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archopht.1995.01100070041022","article-title":"Biochemical quantification of triamcinolone in subconjunctival depots","volume":"113","author":"Kalina","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0065","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0070","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ophtha.2006.03.027","article-title":"Impact of macular edema on visual acuity in uveitis","volume":"113","author":"Lardenoye","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2014.04.010_bib0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0080","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1167\/iovs.11-8193","article-title":"Logarithmic transformation of spectral-domain optical coherence tomography data in uveitis-associated macular edema","volume":"52","author":"Payne","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2014.04.010_bib0085","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.ophtha.2009.12.014","article-title":"A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research","volume":"117","author":"Ferris","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2014.04.010_bib0090","series-title":"Techniques d\u2019exploration de la retine.Vol. 1. Cachan","first-page":"47","author":"Fajnkuchen","year":"2012"},{"key":"10.1016\/j.jfo.2014.04.010_bib0095","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0161-6420(97)30065-7","article-title":"A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications","volume":"104","author":"Thach","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2014.04.010_bib0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/jop.2008.0087","article-title":"Complications and safety profile of posterior subtenon injection of triamcinolone acetonide","volume":"25","author":"Byun","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2014.04.010_bib0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jop.2010.0184","article-title":"Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide","volume":"27","author":"Kawamura","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2014.04.010_bib0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-9394(99)80085-3","article-title":"The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure","volume":"125","author":"Mueller","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0181-5512(08)74383-3","article-title":"[Intravitreous injection: retrospective study on 2028 injections and their side effects]","volume":"31","author":"Angulo Bocco","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0120","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.5301\/EJO.2010.6050","article-title":"General pathophysiology of macular edema","volume":"21","author":"Scholl","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2014.04.010_bib0125","series-title":"Macular edema\u00a0: definition and basic concepts. Macular edema: a practical approach","first-page":"1","author":"Coscas","year":"2010"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551214002502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551214002502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:04:54Z","timestamp":1759259094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551214002502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0181551214002502"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2014.04.010","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 et tol\u00e9rance des injections sous-conjonctivales de triamcinolone dans la prise en charge des \u0153d\u00e8mes maculaires uv\u00e9itiques\u00a0: \u00e9tude r\u00e9trospective sur trente et un cas","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2014.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}